コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ges, which act as important effectors during cancer immunoediting.
2 election process represents one mechanism of cancer immunoediting.
3 sarcomagenesis to investigate the process of cancer immunoediting.
4 oting actions of immunity are referred to as cancer immunoediting.
5 re temporally distinct from IFN-gamma during cancer immunoediting.
6 a broadening of this concept into one termed cancer immunoediting.
7 as a component of a more general process of cancer immunoediting.
8 o identify genes that impact early phases of cancer immunoediting.
9 nomenon related to immune equilibrium during cancer immunoediting.
12 ound that innate immune cells could manifest cancer immunoediting activity in the absence of adaptive
13 are key players in the elimination phase of cancer immunoediting, also referred to as cancer immunos
14 ize the historical and experimental basis of cancer immunoediting and discuss its dual roles in promo
15 tially opening new avenues for comprehending cancer immunoediting and enhancing the conversion of col
16 t compares endogenous versus therapy-induced cancer immunoediting and outlines the molecular and cell
19 01]), and to differentiate between phases of cancer immunoediting concept (odds ratio: 1.17 [95% CI:
21 tumorigenesis or in the elimination phase of cancer immunoediting, did not play critical roles in mai
23 esolution and evolution into the three Es of cancer immunoediting--elimination, equilibrium, and esca
24 s behaviours which resemble the 'three Es of cancer immunoediting': Equilibrium, Escape, and Eliminat
26 and tumor cells interact in a process called cancer immunoediting, giving rise to changes in gene exp
28 articular, the importance of CD8+ T cells in cancer immunoediting has been shown, and more broadly in
31 We also discuss the temporal occurrence of cancer immunoediting in metastases and whether it differ
32 the elimination or the equilibrium phase of cancer immunoediting in the small intestine in this mode
33 nosurveillance constitutes the first step of cancer immunoediting in which developing malignant lesio
34 munosurveillance hypothesis into one termed "cancer immunoediting." In this review, we summarize the
41 munity to control and shape cancer, that is, cancer immunoediting, is the result of three processes t
42 es in immune function that accumulate during cancer immunoediting lead to a progressive escape from h
45 interferons are important components of the cancer immunoediting process and function in a way that
46 imental and human clinical data supporting a cancer immunoediting process that provide the fundamenta
47 anced our understanding of each phase of the cancer immunoediting process, summarizes the discovery o
49 However, many questions about the process of cancer immunoediting remain unanswered, in part because
55 cuss a unifying conceptual framework called "cancer immunoediting," which integrates the immune syste
56 nderstanding of this dynamic process, called cancer immunoediting, will provide important insights in